# Imago BioSciences Inc. (IMGO)

Source: https://www.quantisnow.com/company/IMGO
Generated: 2026-11-12T06:19:06.823Z

- Ticker: IMGO
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- Website: imagobio.com

## About

Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

## Latest IMGO news and filings

- 2025-07-21 11:00 UTC [Omega Funds Closes Oversubscribed $647 Million Fund VIII to Invest in Transformative Life Science Companies](https://www.quantisnow.com/insight/omega-funds-closes-oversubscribed-647-million-fund-viii-to-invest-6126099)
- 2023-02-14 13:26 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Imago BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-imago-biosciences-inc-amendment-4055313)
- 2023-02-01 22:16 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Imago BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-imago-biosciences-inc-amendment-3990388)
- 2023-01-26 13:52 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Imago BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-imago-biosciences-inc-amendment-3957638)
- 2023-01-23 12:25 UTC [SEC Form 15-12G filed by Imago BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-imago-biosciences-inc-3937852)
- 2023-01-20 20:00 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Imago BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-imago-biosciences-inc-amendment-3935103)
- 2023-01-17 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Imago BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-imago-biosciences-inc-3914784)
- 2023-01-12 21:31 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Imago BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-imago-biosciences-inc-amendment-3907223)
- 2023-01-11 21:23 UTC [SEC Form 4] [SEC Form 4 filed by Keating Laurie](https://www.quantisnow.com/insight/sec-form-4-filed-by-keating-laurie-3902089)
- 2023-01-11 21:19 UTC [SEC Form 4] [SEC Form 4: Tapper Amy E. closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-tapper-amy-e-closing-all-direct-ownership-3902060)
- 2023-01-11 21:19 UTC [SEC Form 4] [SEC Form 4 filed by Kariuki Enoch](https://www.quantisnow.com/insight/sec-form-4-filed-by-kariuki-enoch-3902059)
- 2023-01-11 21:17 UTC [SEC Form 4] [SEC Form 4: Rienhoff Hugh Jr closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-rienhoff-hugh-jr-closing-all-direct-ownership-3902021)
- 2023-01-11 21:17 UTC [SEC Form 4] [SEC Form 4 filed by Eichorn Laura G.](https://www.quantisnow.com/insight/sec-form-4-filed-by-eichorn-laura-g-3902014)
- 2023-01-11 21:16 UTC [SEC Form 4] [SEC Form 4: Henner Dennis closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-henner-dennis-closing-all-direct-ownership-in-3902006)
- 2023-01-11 21:16 UTC [SEC Form 4] [SEC Form 4: Arenberg Michael closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-arenberg-michael-closing-all-direct-ownership-in-3901999)
- 2023-01-11 21:13 UTC [SEC Form 4] [SEC Form 4 filed by Chaya Moghrabi Dina](https://www.quantisnow.com/insight/sec-form-4-filed-by-chaya-moghrabi-dina-3901925)
- 2023-01-11 21:13 UTC [SEC Form 4] [SEC Form 4: Chiang Hsiangyi closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-chiang-hsiangyi-closing-all-direct-ownership-in-3901917)
- 2023-01-11 21:12 UTC [SEC Form 4] [SEC Form 4: Peppe Jennifer closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-peppe-jennifer-closing-all-direct-ownership-in-3901915)
- 2023-01-11 21:10 UTC [SEC Form 4] [SEC Form 4: Baltera Robert Jr. closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-baltera-robert-jr-closing-all-direct-ownership-3901897)
- 2023-01-11 15:41 UTC [SEC Form 25-NSE filed by Imago BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-imago-biosciences-inc-3900333)
- 2023-01-11 14:24 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Imago BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-imago-biosciences-inc-3899874)
- 2023-01-11 14:21 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Imago BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-imago-biosciences-inc-3899852)
- 2023-01-11 14:18 UTC [SEC Form POS AM filed by Imago BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-imago-biosciences-inc-3899838)
- 2023-01-11 14:00 UTC [SEC Form 8-K] [Imago BioSciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/imago-biosciences-inc-filed-sec-form-8-k-completion-of-acquisition-3899668)
- 2023-01-11 13:56 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Imago BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-imago-biosciences-inc-amendment-3899423)
- 2023-01-11 13:50 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Imago BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-imago-biosciences-inc-amendment-3899387)
- 2023-01-11 11:45 UTC [Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.](https://www.quantisnow.com/insight/merck-completes-tender-offer-to-acquire-imago-biosciences-inc-3898428)
- 2023-01-05 21:31 UTC [SEC Form 4] [SEC Form 4: Chiang Hsiangyi exercised 19,941 shares at a strike of $4.20, increasing direct ownership by 302% to 26,538 units](https://www.quantisnow.com/insight/sec-form-4-chiang-hsiangyi-exercised-19941-shares-at-a-3879703)
- 2023-01-05 21:30 UTC [SEC Form 4] [SEC Form 4: Arenberg Michael exercised 2,145 shares at a strike of $15.45, increasing direct ownership by 4% to 51,532 units](https://www.quantisnow.com/insight/sec-form-4-arenberg-michael-exercised-2145-shares-at-a-3879652)
- 2023-01-05 21:29 UTC [SEC Form 4] [SEC Form 4: Peppe Jennifer exercised 1,379 shares at a strike of $22.76, increasing direct ownership by 0.93% to 150,188 units](https://www.quantisnow.com/insight/sec-form-4-peppe-jennifer-exercised-1379-shares-at-a-3879630)
- 2023-01-05 21:29 UTC [SEC Form 4] [SEC Form 4: Eichorn Laura G. exercised 37,119 shares at a strike of $4.05, increasing direct ownership by 18% to 246,453 units](https://www.quantisnow.com/insight/sec-form-4-eichorn-laura-g-exercised-37119-shares-at-3879594)
- 2023-01-05 21:28 UTC [SEC Form 4] [SEC Form 4: Tapper Amy E. exercised 21,261 shares at a strike of $4.81, increasing direct ownership by 18% to 141,094 units](https://www.quantisnow.com/insight/sec-form-4-tapper-amy-e-exercised-21261-shares-at-3879586)
- 2023-01-05 21:27 UTC [SEC Form 4] [SEC Form 4: Rienhoff Hugh Jr exercised 12,176 shares at a strike of $2.52, increasing direct ownership by 2% to 501,702 units](https://www.quantisnow.com/insight/sec-form-4-rienhoff-hugh-jr-exercised-12176-shares-at-3879572)
- 2023-01-04 18:02 UTC [Market Insight] [Looking Into Imago BioSciences's Recent Short Interest](https://www.quantisnow.com/insight/looking-into-imago-biosciencess-recent-short-interest-3870049)
- 2023-01-03 21:40 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Imago BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-imago-biosciences-inc-amendment-3865428)
- 2023-01-03 13:10 UTC [Market Insight] [5 Most Expensive Health Care Stocks You Should Worry About](https://www.quantisnow.com/insight/5-most-expensive-health-care-stocks-you-should-worry-about-3861824)
- 2022-12-29 21:07 UTC [SEC Form 4] [SEC Form 4: Eichorn Laura G. exercised 3,100 shares at a strike of $2.52 and sold $111,384 worth of shares (3,100 units at $35.93)](https://www.quantisnow.com/insight/sec-form-4-eichorn-laura-g-exercised-3100-shares-at-3855423)
- 2022-12-29 21:06 UTC [SEC Form 4] [SEC Form 4: Arenberg Michael exercised 95,000 shares at a strike of $17.55 and sold $2,533,352 worth of shares (70,508 units at $35.93), increasing direct ownership by 98% to 49,387 units](https://www.quantisnow.com/insight/sec-form-4-arenberg-michael-exercised-95000-shares-at-a-3855413)
- 2022-12-21 13:14 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Imago BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-imago-biosciences-inc-amendment-3831391)
- 2022-12-21 13:01 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Imago BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-imago-biosciences-inc-amendment-3831304)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/IMGO
- Earnings history: https://www.quantisnow.com/earnings/IMGO
- Dividend history: https://www.quantisnow.com/dividends/IMGO
- Insider transactions: https://www.quantisnow.com/insiders/IMGO
- Options chain: https://www.quantisnow.com/options/IMGO
- SEC 8-K filings only: https://www.quantisnow.com/company/IMGO/8-k
- RSS and alerts for IMGO: https://www.quantisnow.com/docs/rss-feeds.md